Skip to main content
      RT @doctorRBC: We need to work together with our patients to ensure medication adherence during this pandemic.
      1⃣30%

      Robert B Chao, MD doctorRBC

      4 years ago
      We need to work together with our patients to ensure medication adherence during this pandemic. 1⃣30% of 734 pts on DMARDs changed their med use during COVID 2⃣Med change without physician guidance 3⃣Changes resulted in ⬆️steroid use @RheumNow #ACR20 Abs#L05 https://t.co/n18zqed4wC
      RT @MeralElRamahiMD: #ACRbest Largest to date cohort study of pregnancies in women w/ ILD showed no maternal deaths sugg

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years ago
      #ACRbest Largest to date cohort study of pregnancies in women w/ ILD showed no maternal deaths suggesting that women w/ ILD may not need to avoid conception or terminate pregnancies, but pts w/ severe ILD were at higher risk for poor pregnancy outcomes. #Abst1446 @RheumNow
      RT @RichardPAConway: Dr Castillo-Bustamante presents a human otopathological study demonstrating RA involvement of ossic

      Richard Conway RichardPAConway

      4 years ago
      Dr Castillo-Bustamante presents a human otopathological study demonstrating RA involvement of ossicular joints of middle ear. Is there a functional effect on hearing? @rheumnow @bososhea #ACR20 Abstr#1759 https://t.co/iWlKs2KdOW
      RT @Janetbirdope: I recommend you don’t try this at home. Bariatric surgery may delay need for TKA in knee OA. Support

      Janet Pope Janetbirdope

      4 years ago
      I recommend you don’t try this at home. Bariatric surgery may delay need for TKA in knee OA. Supports that et loss may help. Comparison study NOT RCT of 25 bariatric pts with knee OA compared to 28 with TKA abstr#1656 #ACR20 @RheumNow @CRASCRRheum
      RT @RichardPAConway: Dr Sanchez-Bilbao reports a study of 30 patients with LV GCA. Despite clinical remission with tocil

      Richard Conway RichardPAConway

      4 years ago
      Dr Sanchez-Bilbao reports a study of 30 patients with LV GCA. Despite clinical remission with tocilizumab ongoing vascular inflammatory activity identified by PET in 70%. Significant implications for risk of tocilizumab withdrawal. @rheumnow #ACR20 Abstr#1921 https://t.co/f1isidSypn
      RT @ejdein1: There is hope for RA fatigue - improvements seen in F sex, non-smokers, lack of depression, high baseline f

      Eric Dein ejdein1

      4 years ago
      There is hope for RA fatigue - improvements seen in F sex, non-smokers, lack of depression, high baseline fatigue. Abst#1737 @RheumNow #ACR20. Interested in role of exercise in the study. Smoking is BIG cause of fatigue, must address with fatigued RA pts.
      RT @RichardPAConway: Dr Winthrop reports on rates of influenza in RA in tofactinib clinical programme over 14-15 seasons

      Richard Conway RichardPAConway

      4 years ago
      Dr Winthrop reports on rates of influenza in RA in tofactinib clinical programme over 14-15 seasons. No significant differences in rates between tofa, ADA, MTX, and placebo. @rheumnow #ACR20 Abstr#L04 https://t.co/8RrG0I2Zwm
      Kaleb Michauds study from the RA FORWARD registry shows, during the pandemic, significant medication changes (w/o MD co

      Dr. John Cush RheumNow

      4 years ago
      Kaleb Michauds study from the RA FORWARD registry shows, during the pandemic, significant medication changes (w/o MD consult) or appts. These observations show we were not prepared for this and that Rx suffered. #ACR20 Abstr#L05 https://t.co/vrDd0myGos https://t.co/JFUXItVdRQ
      RheumNow’s expanded coverage of the annual #ACR20 meeting is sponsored in part by @Novartis. All content chosen by

      Dr. John Cush RheumNow

      4 years ago
      RheumNow’s expanded coverage of the annual #ACR20 meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
      Deucravacitinib is a novel Tyrosine kinase 2 (TYK2) prev shown efficacy in psoriasis, now effective in PsA. PhII trial o

      Dr. John Cush RheumNow

      4 years ago
      Deucravacitinib is a novel Tyrosine kinase 2 (TYK2) prev shown efficacy in psoriasis, now effective in PsA. PhII trial of 203 PsA patients showed wk 16 significant improvement in ACR20/50/70, enthesitis, SPARC scores. #ACR20 Abstr#L03 https://t.co/LGokmmlyrc
      Here are my highlights from day three, Sunday, of the ACR 2020 Convergence. 
      RT @Janetbirdope: Intra-articulations steroids for the knee OA- finding benefits again! IA steroids were good then vill

      Janet Pope Janetbirdope

      4 years ago
      Intra-articulations steroids for the knee OA- finding benefits again! IA steroids were good then villified in press with accelerated cartilage loss. Pendulum swings back in abstr#1649 where quadriceps & gait improve post injection @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/0bRsiEKsW4
      RT @RichardPAConway: Dr Bergman reports on PROs in RCT of upadacitinib versus abatacept in bDMARD-IR RA patients. Greate

      Richard Conway RichardPAConway

      4 years ago
      Dr Bergman reports on PROs in RCT of upadacitinib versus abatacept in bDMARD-IR RA patients. Greater improvement in PROs with upadacitinib especially in physical functioning, pain, and general health @rheumnow #ACR20 Abstr#1728 https://t.co/NWKrhYAfZn
      RT @uptoTate: @wendycostello2 @psufka @RheumNow Here's the only abstract that I could find from #ACR20 regarding telemed

      Dr. Rachel Tate uptoTate

      4 years ago
      @wendycostello2 @psufka @RheumNow Here's the only abstract that I could find from #ACR20 regarding telemed in pedi rheum clinics. https://t.co/yun6QCv4fX It doesn't answer your question but it may be helpful to consider follow up with the authors.